Method for treating TNF alpha-related disease

A method for the treatment of rheumatoid arthritis comprising a step of administering to a patient a pharmaceutical composition comprising infliximab, wherein infliximab is administered subcutaneously to the patient at a dose of 120 mg and at intervals of 2 weeks.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	AN, Hyun Chul, SUH, Jee Hye, LEE, Sung Young, KIM, Sun Jung
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A method for the treatment of rheumatoid arthritis comprising a step of administering to a patient a pharmaceutical composition comprising infliximab, wherein infliximab is administered subcutaneously to the patient at a dose of 120 mg and at intervals of 2 weeks.